INmune Bio Inc. short interest in 2022
In 2022, INmune Bio Inc.'s disclosed short interest ran from 5.92% of shares outstanding on 14 Jan 2022 to 5.27% on 30 Dec 2022, a change of -0.65 percentage points. The year's high was 7.21% on 13 May 2022 and its low 4.95% on 30 Nov 2022, averaging 5.74% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 26.61 days on 30 Nov 2022. Full history: INmune Bio Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 5.92% (14 Jan 2022)
- End of year
- 5.27% (30 Dec 2022)
- Change
- -0.65 pp
- High
- 7.21% (13 May 2022)
- Low
- 4.95% (30 Nov 2022)
- Average
- 5.74%
- Highest days to cover
- 26.61 (30 Nov 2022)
- SEC filings marked
- 8
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 5.92% | 7.41 | |
| 31 Jan 2022 | 6.14% | 5.74 | |
| 15 Feb 2022 | 5.94% | 8.85 | |
| 28 Feb 2022 | 6.39% | 8.61 | |
| 15 Mar 2022 | 5.81% | 5.22 | 10-K filed, results (8-K) |
| 31 Mar 2022 | 6.59% | 9.58 | |
| 14 Apr 2022 | 6.00% | 9.41 | |
| 29 Apr 2022 | 7.01% | 8.07 | |
| 13 May 2022 | 7.21% | 11.47 | 10-Q filed, results (8-K) |
| 31 May 2022 | 5.73% | 4.17 | |
| 15 Jun 2022 | 6.14% | 12.70 | |
| 30 Jun 2022 | 6.02% | 9.74 | |
| 15 Jul 2022 | 5.62% | 14.79 | |
| 29 Jul 2022 | 5.46% | 19.54 | |
| 15 Aug 2022 | 5.40% | 16.14 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 5.52% | 20.47 | |
| 15 Sep 2022 | 4.97% | 23.21 | |
| 30 Sep 2022 | 5.14% | 12.60 | |
| 14 Oct 2022 | 5.12% | 17.00 | |
| 31 Oct 2022 | 5.23% | 24.83 | |
| 15 Nov 2022 | 5.07% | 22.14 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 4.95% | 26.61 | |
| 15 Dec 2022 | 5.09% | 17.93 | |
| 30 Dec 2022 | 5.27% | 18.00 |
See also: INmune Bio Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.